Results 101 to 110 of about 5,434 (169)

Intratumoral TIGIT blockade augments antitumor responses and bypasses increased functionality of peripheral TIGIT+ NK cells in mouse and human models of bone and soft tissue sarcoma. [PDF]

J Immunother Cancer
Lammers ML, Sholevar CJ, Karimzadeh M, Razmara AM, Cruz SM, Purl MC, Liu NM, Bakke D, Plagens RN, Elliott A, Sheng MK, Dongen CV, Tran T, Trinh AT, Nielsen RN, Kotamraju T, Farley LE, Iranpur KR, Mukarrama T, Gronchi A, Riedel RF, Monjazeb AM, Thorpe SW, Darrow MA, Kim J, Murphy WJ, Judge SJ, Canter RJ.   +27 more
europepmc   +1 more source

CD155 links tumor immunotype to epithelial-directed precision therapy beyond checkpoint inhibition in cervical cancer. [PDF]

J Immunother Cancer
Verhoeven Y, Quatannens D, van der Heijden S, Claes J, de Beukelaar J, Lambrechts H, Hermans C, Broeckx G, Van Dijck H, Ramadhan A, Zwaenepoel K, Stoop H, Van Laere S, Hauspy J, Faes C, van Kempen LC, Trinh XB, Lardon F, Koljenovic S, van Dam PA, De Waele J.   +20 more
europepmc   +1 more source

Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer. [PDF]

Cancer Diagn Progn
Lehrer S, Rheinstein PH.
europepmc   +1 more source

Targeting the TIGIT/CD155-induced metabolic checkpoint in NK cells restores anti-tumor immunity and suppresses hepatocellular carcinoma growth. [PDF]

Front Immunol
Shu J, Yu W, Shen Y, Liu X.
europepmc   +1 more source

Isorhamnetin inhibits migration and promotes apoptosis via modulation of oxidative stress, mitochondrial dysfunction, and the TIGIT/CD155 axis in 4T1 breast cancer cells. [PDF]

Front Cell Dev Biol
Chen F, Liu Y, Zhang H, Yang Q, Li G, Zhu Y, Zhang R.   +6 more
europepmc   +1 more source

The Expression of CD155 on Renal Cell Carcinoma Cells

Advances in Clinical Medicine, 2019
openaire   +1 more source

Precision virotherapy for IDH-mutant astrocytoma. [PDF]

Mol Ther Oncol
Panagioti E, Lawler SE, Yaffe MB, Chiocca EA, Cook CH.   +4 more
europepmc   +1 more source

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6. [PDF]

Proc Natl Acad Sci U S A
Fassl A, Palacios Espinoza M, Butter D, Kolodziejczyk A, Seehawer M, Hill C, Ning X, Branigan TB, Peñailillo J, Saengboonmee C, Jadhav H, Charbonnier LM, Waks AG, Strawser C, McDonnell DP, Shapiro GI, Tolaney SM, Polyak K, Sammons S, Wucherpfennig KW, Sicinski P.   +20 more
europepmc   +1 more source

Inhibitory immune checkpoints in preeclampsia: current landscape, mechanisms, and clinical perspectives. [PDF]

Front Immunol
Liu M, Duan G, Lai X, Lin B, Li X, Yang J, Cao S, Chen H, Wang T, Chen B, He Z, Ma Q, Duan C, Zhu Y, Lu Y, Gao Y.   +15 more
europepmc   +1 more source